Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
16%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
SBIO
84
HOLDINGS
14%
ALSO IN IBRN
IBRN
73
HOLDINGS
28%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
DIANTHUS THERAPEUTICS INC | 3.1% | 3.7% | 3.1% |
|
EDGEWISE THERAPEUTICS, INC. | 2.9% | 4.4% | 2.9% |
|
ACADIA PHARMACEUTICALS INC | 2.3% | 3.5% | 2.3% |
|
DYNE THERAPEUTICS INC | 2.1% | 3.4% | 2.1% |
|
SAREPTA THERAPEUTICS INC | 1.3% | 2.8% | 1.3% |
SBIO Overweight Relative to IBRN
|
CG ONCOLOGY, INC. | 3.8% |
|
VERADERMICS INC | 3.6% |
|
ORUKA THERAPEUTICS INC | 3.5% |
|
TRAVERE THERAPEUTICS, INC. | 3.3% |
|
DEFINIUM THERAPEUTICS INC | 3.1% |
|
RELAY THERAPEUTICS, INC. | 2.6% |
|
IDEAYA BIOSCIENCES, INC. | 2.4% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.3% |
|
TARSUS PHARMACEUTICALS, INC. | 2.1% |
|
DENALI THERAPEUTICS INC. | 2.0% |
SBIO Underweight Relative to IBRN
|
BIOGEN IDEC INC | -5.0% |
|
PTC THERAPEUTICS INC | -4.6% |
|
NEUROCRINE BIOSCIENCES INC | -4.5% |
 |
ALKERMES PLC | -4.3% |
 |
ARGENX SE ADR | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.7% |
|
SUPERNUS PHARMACEUTICALS INC | -3.6% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.2% |
|
AXOGEN, INC. | -2.9% |
|
EDGEWISE THERAPEUTICS, INC. | -1.6% |